Proteome- and Methylation Profiles in Oropharyngeal Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04567082

Acronym

PROMEO

Enrollment

Registered

2020-09-28

Start date

2020-09-25

Completion date

2024-01-31

Last updated

2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharynx Cancer

Brief summary

This clinical study aims to evaluate proteome- and methylation profiles in saliva in patients with oropharyngeal cancers

Interventions

DIAGNOSTIC_TESTExamination of saliva

Collection of saliva samples

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Cancer group: Inclusion Criteria: * Written informed consent * Verified oropharyngeal squamous cell carcinoma

Exclusion criteria

* Other active cancer * Uncontrolled comorbidity * Unable to give informed consent Control group: Inclusion Criteria: * Written informed consent * Normal ENT examination

Design outcomes

Primary

Measure	Time frame	Description
Differences in proteome and methylation profiles	At diagnosis	Differences between cancer- and control group

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026